Related Experiment Video

Updated: Mar 29, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

1.3K

Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease

Nicoleta Alexandru, Ana Costa, Alina Constantin

  • 1Pathophysiology and Pharmacology Department, Institute of Cellular Biology and Pathology 'Nicolae Simionescu' of Romanian Academy, 8, BP Hasdeu Street, PO Box 35-14, 050568-Bucharest, Romania.

Current Stem Cell Research & Therapy
|December 10, 2015
PubMed

Insights

Microparticles (MPs) are key players in cardiovascular diseases (CVD), acting as biomarkers and influencing atherosclerosis and thrombosis. Understanding their role can improve CVD diagnosis and management.

Area of Science:

  • Biomedical research
  • Cardiovascular science
  • Cell biology

Background:

  • Cardiovascular diseases (CVD) are a leading cause of global mortality.
  • Atherosclerosis and hypertension are common triggers for CVD.
  • Traditional risk factors and emerging biomarkers are crucial for CVD risk stratification.

Purpose of the Study:

  • To review the multifaceted roles of microparticles (MPs) in cardiovascular diseases.
  • To explore MPs as potential diagnostic tools and therapeutic targets.
  • To discuss the impact of MPs on atherosclerosis, inflammation, and thrombosis.

Main Methods:

  • Literature review of studies on microparticles and cardiovascular diseases.
  • Analysis of the biological functions and clinical relevance of MPs.
  • Synthesis of current knowledge on MPs in CVD pathogenesis.

Main Results:

  • Microparticles (MPs) are vesicles released from cells, involved in intercellular signaling.
  • MPs are associated with disease states and play significant roles in atherosclerosis, inflammation, and thrombosis.
  • MPs show potential as non-invasive biomarkers for CVD diagnosis and prognosis.

Conclusions:

  • Microparticles offer novel insights into CVD pathogenesis and progression.
  • MPs can serve as valuable diagnostic and prognostic tools in cardiovascular medicine.
  • Further research into MPs' dual impact is essential for optimizing CVD management.

Keywords:
Biomarkerscardiovascular diseasediagnostic toolsmicroparticles.

More Related Videos

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging09:43

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

1.9K
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.8K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
742
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.9K
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
27